Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by MAIN, D. M. G.
Right arrow Articles by CHAMBERLAIN, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MAIN, D. M. G.
Right arrow Articles by CHAMBERLAIN, M. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1992 British Society for Rheumatology

research-article

CLINICAL DIFFERENTIATION OF ORAL ULCERATION IN BEHÇET'S DISEASE

D. M. G. MAIN and M. A. CHAMBERLAIN

Departments of Dental Surgery and Medicine, University of Leeds

Correspondence to: Correspondence to D. Main Department of Dental Surgery, School of Dentistry, Oarendon Way, Leeds LS2 9LU.

Behçet oral ulceration (BOU) is described as being indistinguishable from conventional recurrent oral ulceration (ROU). A clinical comparison between 38 Behçet patients and 38 control ROU cases was effected by completion of a standard questionnaire. Behçet patients reported an increased number of concurrent ulcers and involvement of the soft palate and oropharynx. No differences were detected with respect to duration, frequency, age of onset or family history. In addition, photographs of BOU in 15 patients revealed the concurrence of atypical aphthous and herpetiform varieties. Number, site and appearance of oral ulceration may therefore provide diagnostic features for the development of Behçet's disease.

KEY WORDS: Oral ulceration, Behçet's disease, Clinical features


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Dent. Res.Home page
L.M. Al-Otaibi, S.R. Porter, and T.W.J. Poate
Behcet's Disease: A Review
J. Dent. Res., March 1, 2005; 84(3): 209 - 222.
[Abstract] [Full Text] [PDF]

Home page
 FAKE JDRHome page
L.M. Al-Otaibi, S.R. Porter, and T.W.J. Poate
Behcet's Disease: A Review
Journal of Dental Research, March 1, 2005; 84(3): 209 - 222.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
I Kotter, M Zierhut, A K Eckstein, R Vonthein, T Ness, I Gunaydin, B Grimbacher, S Blaschke, W Meyer-Riemann, H H Peter, et al.
Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis
Br. J. Ophthalmol., April 1, 2003; 87(4): 423 - 431.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
V Kontogiannis and R J Powell
Behcet's disease
Postgrad. Med. J., October 1, 2000; 76(900): 629 - 637.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.